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Genome editing has now been reported in many sys-
tems using TALEN andCRISPR-Cas9 nucleases. Pre-
cise mutations can be introduced during homology-
directed repair with donor DNA carrying the wanted
sequence edit, but efficiency is usually lower than for
gene knockout and optimal strategies have not been
extensively investigated. Here, we show that using
phosphorothioate-modifiedoligonucleotidesstrongly
enhances genome editing efficiency of single-
stranded oligonucleotide donors in cultured cells. In
addition, it provides better design flexibility, allowing
insertionsmore than100bp long.Despite previous re-
ports of phosphorothioate-modified oligonucleotide
toxicity, clones of edited cells are readily isolated
and targeted sequence insertions are achieved in
rats and mice with very high frequency, allowing
for homozygous loxP site insertion at the mouse
ROSA locus in particular. Finally, when detected,
imprecise knockin events exhibit indels that are
asymmetrically positioned, consistent with genome
editing taking place by two steps of single-strand
annealing.
INTRODUCTION
Pioneer studies with I-Sce1 and zinc finger nucleases were
used to establish the main principles of genome editing
with sequence-specific nucleases (Porteus and Carroll, 2005).
TALENs and even more spectacularly CRISPR-Cas9 have now
hugely facilitated the design of sequence-specific nucleases to
the target locus of interest, which is no longer the limiting step
in genome editing (Hsu et al., 2014; Kim and Kim, 2014). When
a double-strand break takes place, DNA repair usually proceedsCewith fidelity to the original sequence (Be´termier et al., 2014).
However, when sequence-specific nucleases are used, muta-
tions are introduced at high rates, possibly due to repeated
cleavage and repair cycles until mutations disrupt cleavage
site recognition. The DNA double-strand break repair pathways
involved are thought to be mainly classical non-homologous
end joining (NHEJ) and possibly alternative end joining (altEJ or
MMEJ; Bae et al., 2014) that bothmediate DNA ligation after pro-
cessing of chromosomal ends. Other well-characterized path-
ways for DNA double-strand break repair are homology directed,
for instance, homologous recombination using the sister chro-
matid during cell replication. For purposes of genome editing,
donor DNA can be introduced into cells in order to program
the sequence modification resulting from homology-directed
repair. Several types of donor DNA have been used including
plasmid DNA and synthetic oligonucleotides (Carroll and
Beumer, 2014). Plasmid DNA with 1 kbp homology arms to
sequence flanking the cleavage site is commonly used in
gene-targeting experiments in mammalian cells. However, using
CRISPR-Cas9 nucleases, it was found that homology arms
longer than 1 kbp could stimulate gene-targeting efficiency by
2- to 4-fold (Chu et al., 2015), suggesting that specific optimiza-
tion may be beneficial. Recently, DNA plasmids with very short
homology arms, around 10 bp long, were shown to drive tar-
geted insertion, likely by a MMEJ-based mechanism (Nakade
et al., 2014). Single-stranded oligonucleotide (ssODN) donors
have also been used successfully in many experimental sys-
tems, including cultured cells (Chen et al., 2011; Ran et al.,
2013) and embryo injections (Beumer et al., 2013b; Harel et al.,
2015; Paix et al., 2014; Shao et al., 2014; Tan et al., 2013).
Stretches of homology to the sequence flanking the cleavage
site are usually included in the ssODN design (Chen et al.,
2011). In the mouse and rat, precise insertions and point muta-
tions have been achieved at high efficiencies with ssODN donors
(Yang et al., 2014; Yoshimi et al., 2014), whereas in zebrafish,
extensive mutations of the ssODN or target site sequence
were found in the great majority of insertions (Bedell et al.,ll Reports 14, 2263–2272, March 8, 2016 ª2016 The Authors 2263
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Figure 1. Optimization of Short ODN Donor
Design
(A) Integration activity of short ss- and dsODN donors.
TALEN target sequences (in bold) and PAM sequence (in
lower cases) in an intron of the PPP1R12C gene within
the chromosome 19 locus are shown. Single-stranded
donor oligonucleotides (ssODNs) with short homology
arms, ss1s (43-mer) and ss2s and ss3s (58-mer), and
the 58-bp DS3 duplex (formed by hybridization of ss3s
with its complementary strand) were used to make a
sequence insertion including a PvuII site at the cleavage
site. A control ssODN including a PvuII site but lacking
homology arms, GFPss2s-PS, was also used. Double-
stranded donors (dsODNs) (different versions of DS1
and DS2, as indicated) included an XhoI site (see se-
quences in Tables S1 and S2 and Figure S1). dsODNs
containing microhomologous ends (DS1-mhDS-PS,
DS1-50mh-PS, DS2-50mh-PS, DS2-50mh-PO, and DS1-
30mh-PS) or not (DS1-blunt-PS, DS1-bluntP-PS, and
DS2-50scr-PS) were evaluated. RFLP analysis of DNA
from U2OS cells treated with TALEN AAVS1 or
(sgT2+Cas9) and various ssODNs (at 12 mg, except
ss2s-PS at 6, 9, and 12 mg) or dsODNs (at 12 mg) is
shown. The corresponding rate of PvuII or XhoI cleavage
(% RFLP) and of mutations evaluated in parallel by the
T7 endonuclease I assay, T7E1 (indicated as % indels;
gel not shown) are reported below the gel. PO,
phosphodiester; PS, phosphorothioate. Fifty-base-pair DNA ladder (NEB) was shown. See also Figure S1 for integration activity of dsODNs.
(B) ssODNs, but not dsODNs, direct precise sequence insertions. The frequency of the different types of indels, evaluated by deep sequencing, are reported: %
indels w/o KI (gray) and KI events that include the precise KI events (black) and KI with additional indels (hatched).
(C) Influence of location and nature of the modification in the oligonucleotide on genome editing efficiency. Different parameters were evaluated: the type of
chemical modification (LNA [locked nucleic acid]), the number of modified nucleotides (two at both ends or at 30 end in ss2sPS or ss2sPS_30, resp.; three at both
ends or at the 30 end in ss2s-3PS or ss2s-3PS_30 and ss2s-3LNA_30, resp.). RFLP rate is shown for different modified oligonucleotides, as mean ± SD (3–20
independent experiments). For all the modified ssODNs compared to the POODN, p values fromMann-Whitney statistical analysis are <0.05. See also Figure S2
for impact of polarity of the PS-ssODN and of distance between break and gene edit (Figure S2A) and of homology length on activity of PO-ODNs (Figure S2B).2012; Gagnon et al., 2014; Hruscha et al., 2013), therefore much
limiting the use of ssODN donors in zebrafish.
We chose to more systematically test the potential of chemi-
cally modified ssODNs or double-stranded ODNs (dsODNs) for
genome editing with sequence-specific nucleases. We investi-
gate several parameters including the nature and location of
modified bases, length of sequence insertion, and distance to
cleavage site position. Different types of nucleases were tested,
both TALENs and CRISPR-Cas9 nucleases, for genome editing
in multiple experimental systems, including cultured cells and
model organisms. Our results show that phosphorothioate
(PS)-modified ssODNs exhibit improved efficiency and flexibility
in most experimental systems tested. Interestingly, detailed
analysis of gene edits reveals a variable proportion of imprecise
sequence insertions, which could be due to different mecha-
nisms of double-strand break repair by ssODNs.
RESULTS
Design and Activity of Short ss- or dsODN Donors
We first evaluated the homology-directed repair (HDR) capacity
of ODNswith short homology arms.We tested both ssODNs and
dsODNs to generate small insertions, and in each case, we eval-
uated different designs. ssODNs have been shown to be effec-
tive in genome editing, but several questions remain concern-
ing how to optimize their design. Regular phosphodiester (PO)2264 Cell Reports 14, 2263–2272, March 8, 2016 ª2016 The AuthorsssODNs of around 100 nucleotides (nt) long have been success-
fully used (Chen et al., 2011; Yang et al., 2013). We first tested
chemically modified ssODNs for HDR. We started with the com-
mon PS modification, known to improve nuclease resistance
(Eckstein, 2000). We designed ssODNs with short homology
arms, ss1s, with 18 and 19 on each side of the break, and ss2s
or ss3s, with 27 or 28 and 24 nt (see Table S1 for sequences).
PS chemical modifications were incorporated at two terminal nu-
cleotides of both 50 and 30 ends. Using AAVS1 as a test locus, we
introduced a PvuII restriction site sequence in ssODN (Figure 1A)
for easy analysis of sequence insertion by restriction fragment
length polymorphism (RFLP). We chose to insert the PvuII site
directly into the expected cleavage site for the sequence-spe-
cific nucleases used here, AAVS1-specific TALEN with ss1s
and ss2s and Cas9 combined with sgT2 guide RNA with ss3s.
ssODN donors were co-transfected with AAVS1-specific TALEN
or Cas9 and sgT2 guide RNA expression plasmids. Fourteen
days post-transfection, the AAVS1 locus was amplified by
PCR and donor insertion into the AAVS1 site assayed by PvuII
digestion (Figure 1A). PS-modified ssODNs (ss1s-PS and ss2s-
PS) directed robust sequence insertion efficiency in the pres-
ence of nucleases, whereas the corresponding unmodified
ssODNs (ss1s-PO and ss2s-PO) led to only modest integration
levels (6% versus 15% and 4% versus 14%, respectively). The
knockin (KI) rates using PS-modified ssODNs were in the range
of indel rates induced by nucleases at this site as measured by
the T7 endonuclease assay (T7E1), suggesting that the majority
of modification events were donor-mediated insertions. A PS-
ssODN including a PvuII site but lacking homology arms,
ssGFPss2s-PS, did not induce any sequence insertion, as ex-
pected for an HDR-based mechanism. Finally, using the duplex
version of the ODN donor (DS3) strongly decreased the integra-
tion rate (by 2-fold), consistent with a mechanism different from
homologous recombination being involved for ssODNs.
Based on results showing that donors with microhomologies
to the cleavage site ends can enable efficient integration of
DNA fragments by MMEJ (microhomology-mediated end-
joining) (Nakade et al., 2014; Orlando et al., 2010), we chose to
evaluate the potential of dsODNs with microhomologies for inte-
gration at the Cas9 cleavage site directed by guide RNA sgT2.
Based on the fact that cleavage sites are processed during
repair, generating different types of DNA ends (Dorsett et al.,
2014), we tested different types of microhomologous ends,
either double-stranded (mhDS), single-stranded 30 overhangs
(30mh), or single-stranded 50 overhangs (50mh) (see sequences
in Figure S1 and Table S2). As above, two PS nucleotide residues
were included at 50 and 30 ends of dsODNs and the sequence
insertion consisted of an exogenous 40- or 46-bp sequence
(DS1 or DS2, respectively) including an Xho1 restriction site.
Control donor oligonucleotides were used that had either no ho-
mology (DS1-blunt-PS and DS1-bluntP-PS; a 50 phosphorylated
version of the former) or 8 nt 50mh predicted not to base pair with
the sequence at the cleavage site (DS2-50scr-PS). These dsODN
donors were co-transfected with Cas9 and sgT2 guide RNA
expression plasmids. Six days post-transfection, the AAVS1 lo-
cus was amplified by PCR and sequence insertion into the
AAVS1 site assayed by XhoI digestion (Figure 1A). As observed
with ssODN donors, the PSmodification strongly enhanced inte-
gration of duplex donors (14% compared to 5% for DS2-50mh-
PS and -PO, respectively). Sequence insertion was observed
for all the designs tested but at different rates (Figure S1B). In
particular, as recently reported, dsODN with blunt ends inte-
grated at frequencies corresponding roughly to 1/2 indel muta-
tion rates (Tsai et al., 2015). Importantly, the duplex with the
non-complementary overhangs (DS2-50scr-PS) also led to XhoI
sequence insertion. These results were confirmed at another
cleavage site, at the SOD1 gene (Figure S1C). At this target,
blunt and overhang-containing duplexes also led to targeted
donor sequence insertion regardless of the presence of micro-
homologous ends (4% and 9% for DS2-sod50mh-PS and DS2-
sod-30mh-PS, which had microhomologous ends, compared to
7% and 11% for DS2-50mh-PS or DS1-blunt-PS, without), indi-
cating that there is no need for microhomologous ends to
achieve efficient integration. This finding suggested that impre-
cise sequence insertions were taking place.
ssODNs, but Not dsODNs, Direct Precise Sequence
Insertion
To determine the fidelity of donor sequence insertion, the PCR
amplicon from the AAVS1 target was subjected to deep seq-
uencing. For ssODNs, the majority of insertion events were pre-
cise (representing more than 90% of total KI events) and only a
low frequency of imprecise insertions was detected (indicated
as ‘‘KI+indels’’ with hatched bars; representing less than 10%Ceof total KI events; Figure 1B). With the short duplex donors,
sequence information in the microhomology arms was expected
to result in precise donor sequence insertion without loss of
either chromosomal or donor sequence. However, only few inte-
gration events were precise. Poor efficiency of precise insertion
could be due to insufficient levels of available complementary
‘‘acceptor’’ ends after target sequence cleavage by Cas9, which
is known to generate blunt ends (Jinek et al., 2012). Recent
studies using TALENs or CRISPR-Cas9 and DNA plasmid
donors containing microhomologies, although demonstrating
precise MMEJ-based integration, also exhibited significant
amounts of imprecise integration events (Nakade et al., 2014).
In contrast, previous studies that showed efficient precise inser-
tion with dsODN donors carrying microhomologies were per-
formed with zinc finger nucleases that generate 50 protruding
ends (Orlando et al., 2010).
Chemical Modifications of ssODNs Stimulate Genome
Editing
Based on the sequencing data, we next focused on ssODNs do-
nors that were the most efficient for precise sequence insertion.
We evaluated a set of ssODNs in order to determine parameters
impacting genome editing efficiency. We first performed exper-
iments to assay the importance of the nature and location of
chemical modifications. PS modifications were positioned at
both ends, as above, or at 30 end only, and we compared effi-
ciency of two to three PS-modified nucleotides. In addition to
PS modification, we selected LNA, locked nucleic acid, known
to improve ODN chemical and thermal stability (Jepsen and
Wengel, 2004). Donor insertion into the AAVS1 site was assayed
as described above by RFLP analysis. All the chemically modi-
fied donors strongly enhanced donor sequence insertion com-
pared to the PO-ssODN donor (Figure 1C). These data are
consistent with a model in which ssODN end modifications
enhance intracellular stability, thus enabling increased efficacy
of genome editing.
Because chemical modifications, especially PS, have been
described to be toxic (Rios et al., 2012), we carefully investigated
the long-term survival and proliferation of modified cells. Seq-
uence insertion rates were found to remain unchanged up to
15 days after treatment, whether using an ssODN containing
PS modifications or standard PO chemistry.
We designed ssODN donors of variable sense and antisense
orientations (s and as). At the AAVS1 locus, the antisense donor,
ss2as-PS, used with the AAVS1-specific TALEN, was slightly
but significantly more efficient than the sense donor, ss2s-PS
(Figure 1C; p = 0.008 from Mann-Whitney statistical analysis).
However, in all the situations that we have tested (for example:
AAVS1 locus in Figure S2A; GFP transgene in Figure S4C),
both orientations worked, sometimes with slightly different effi-
ciencies, but no general rule emerged for sense or antisense
orientation preference.
Improved Flexibility of Genome Editing Using PS-ssODN
Donors
We next investigated the effect of homology length on gene edit-
ing in the context of ssODN donors and assayed targeted
sequence insertion at the AAVS1 locus (Figure S2B). In previousll Reports 14, 2263–2272, March 8, 2016 ª2016 The Authors 2265
work using PO-ssODNs, lengths in the range of 100 nt were com-
mon in most applications. We compared the ss1, ss2, and ss95
donors with 37, 51, and 84 nt total homology regions, respec-
tively. As already shown in Figure 1A, short ss1-PO and ss2-
PO donors drive limited donor sequence insertion compared to
their PS counterparts. Using longer PO donors with an 84-nt total
homology ss95-PO can strongly improve the activity compared
to 51 nt (22% for ss95-PO compared to 5% for the same concen-
tration of ss2-PO; Figure S2B). This observation was confirmed
on SUFU gene, extending from a 73- to a 97-nt total homology
region (43% for Sufu-1FLAG-L-PO versus 12% for the same
concentration of Sufu-1FLAG-PO; Figure S2B). Although un-
modified PO-ssODNs are intrinsically less efficient than chemi-
cally modified ones, using longer PO donors at high concentra-
tions can compensate for their lower activity, possibly because
sufficient homology is preserved from exonuclease degradation
to maintain activity. However, lengthening of the homology
above 90–100 nt has been described to be detrimental (Yang
et al., 2013), likely because it could be prone to secondary struc-
tures decreasing the amount of donor effectively available for
gene editing. In addition, using long homologous regions limits
the size of functional sequences that can be inserted because
chemical synthesis allows robust production of ssODNs no
longer than 200 nt.
When using ssODN donors for sequence insertion, DNA cleav-
age is commonly designed to take place less than 10 bp away
from the desired insertion site (Yang et al., 2013). In experiments
described above, we designed the ssODN donors (ss1, 2, and 3)
to make the insertion exactly at the expected cleavage site. We
therefore wanted to examine in more detail how the rate of
sequence insertion varies with its distance to the cleavage site.
We tested a combination of nuclease and ssODN donor pairs
(TALEN, sgT2, sgU2, and sgS1 and ss2, ss2L, and ss4; Fig-
ure S2A), generating DSBs at various distances from the insertion
position. Here, we observed robust efficiency for sequence inser-
tions at distances from 8 to 20 bp (Figure S2A), further establish-
ing the flexibility of ssODN design when using PS modifications.
Efficient Gene Tagging with a 102-bp Insert Using
PS-ssODNs
To demonstrate the general applicability of our results, we further
tested similar reagents at different genomic loci and cell lines.
The optimized ODN design was tested on different genes in
Hedgehog signaling, a major signaling pathway in development
and oncogenesis. We sought to introduce FLAG-tag coding se-
quences as a typical application of genome editing that should
facilitate functional characterization of proteins for which anti-
body resources are limited. First, different amounts of PS- and
PO-ssODNs were co-transfected in U2OS cells with TALENs
targeting the ATG start codon of the SUFU protein coding
sequence. Interestingly, as shown at the AAVS1 locus, PS-
ssODNs resulted in higher efficiency of FLAG-tag sequence inte-
gration (36% for Sufu-1FLAG-PS compared to 12% for -PO for
example at the higher dose and 27% versus 1% at the lower
dose; Figure 2A). The insertion size is limited by ODN synthesis
capacity and length of homology arms. Considering that we
can use shorter homology sequences by including PS modifica-
tions, we tested whether PS- ssODN would allow making longer2266 Cell Reports 14, 2263–2272, March 8, 2016 ª2016 The Authorssequence insertions. As shown in Figure 2A, we found that using
PS-modified ssODN allowed very efficient insertion of more
than 100 bp whereas only limited integration could take place
with non-modified ssODN (53% for Sufu-3FLAG-HA-PS versus
3% for -PO), demonstrating a striking advantage of modified
compared to non-modified ssODNs. To further generalize our
findings, we tested insertion of FLAG-tag coding sequences in
a series of genes of the Hedgehog signaling pathway (SUFU,
GLI2, GLI3, MLF1, SMO, and KIF7 genes) in U2OS cells and in
a non-transformed RPE1 human cell line (Figure 2B). Efficient
insertion could be induced at all loci tested by co-transfection
of modified ssODNs with TALENs targeting the corresponding
sequences. In the absence of TALEN co-transfection or when
using control oligonucleotide with no sequence homology to
the target, we could not detect FLAG-tag coding sequence inte-
gration by PCR. We further exploited the use of short modified
ssODNs to evaluate the FLAG-tag insertion at two genes simul-
taneously. Transfection of the corresponding pairs of nucleases
and donors gave rise to efficient insertion at both targets (SUFU
and GLI2 genes; Figure S2C). When comparing results between
the two cell lines, we observed that KI rates were higher in U2OS
(KI rates ranging between 20% and 50%) than in RPE1 cells (KI
rates ranging from 2% to 12%; Figure 2B), possibly due to differ-
ences in nuclease cleavage efficiencies and/or intrinsic differ-
ences in activities of DNA repair pathways. Importantly, in
RPE1 cells, KI events at all loci tested could only be easily de-
tected with PS- and not PO-ssODNs donors (for example, 5%
for Sufu-1FLAG-PS versus 0% for -PO and 4% for Sufu-
3FLAG-HA-PS versus 1% for -PO; Figure 2B, lower panel).
Efficient Isolation of Tagged Cell Clones with
PS-ssODNs
We next examined whether cells carrying the genome edits of in-
terest could be isolated. Given the high frequencies of genome
editing observed (see Supplemental Experimental Procedures),
we seeded cells at clonal density and directly isolated and
analyzed a series of clones. Targeted genome editing was
analyzed at the DNA and protein levels. We could readily isolate
clones carrying the integration of tag-coding sequences either at
one or at multiple alleles in U2OS and in RPE1 cells (Figure 2C).
The rate of KI alleles in the clones analyzed was roughly equiva-
lent to the KI rates measured in the initial cell population, there-
fore supporting the absence of specific toxicity of PS-ssODNs.
Fewer positive clones were isolated in RPE1 cells, as expected
from the lower genome editing efficiency compared to U2OS
cells. At the protein level, it was possible to detect tagged
SUFU proteins with anti-FLAG antibody in positive clones from
both cell lines, with the expected signal amplification for the
clones containing the 3FLAG-tagged Sufu protein compared to
1FLAG-tag. The readily achieved isolation of modified clones
showed that treatment of cells with PS-modified ODNs was
compatible with long-term expansion of modified cells.
Successful KI in Rat, Mouse, and Zebrafish with
PS-ssODNs
We next wanted to examine the potential of modified ssODNs in
genome editing of model organisms, both testing the benefit of
modified ssODNs compared to PO-ODNs and further checking
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Figure 2. Efficient Tag Sequence Insertion of
More Than 100 bp Using Modified ODNs at
Genes of the Hedgehog-Signaling Pathway
TALENs and ssODNs were designed to perform
insertion of FLAG-tag coding sequences at the ATG
or STOP codon positions of the indicated genes in
the Hedgehog-signaling pathway. DNA was ex-
tracted and PCR amplified to evaluate the efficiency
of FLAG-tag sequence insertion and perform the
T7E1 assay. % KI indicates the relative abundance
of the higher size band corresponding to FLAG-tag
sequence insertion relative to the total DNA bands.
% indels indicates the mutation rates calculated
from the T7E1 assay results and %T7E1 the
cleavage rate by T7E1 (gel not shown). Note that,
when provided, indels rates were calculated by
taking into account the KI population, as detailed in
Experimental Procedures.
(A) SUFU gene tagging in U2OS cells. TALEN target
sequences (in bold) around the start codon (lower
cases) of the SUFU gene are shown. ssODNs
containing insertion of one FLAG-tag sequence
(24 bp), Sufu-1FLAG-PS, and Sufu-1FLAG-PO or
3FLAG-HA sequence (102 bp), Sufu-3FLAG-HA-
PS, and Sufu-3FLAG-HA-PO were used at different
doses with TALEN expression plasmid (for Sufu-
1FLAG-PS and Sufu-1FLAG-PO: 15, 12, 9.6, 7.2,
and 4.8 mg or 15 mgwith ssODN alone; 6 mg for Sufu-
3FLAG-HA-PO and Sufu-1FLAG-PS). Fifty-base-
pair DNA ladder is shown on the right.
(B) Targeting of Hedgehog-signaling genes in
U2OS and RPE1 cells. PS-ssODNs containing one
FLAG-tag coding sequence were used (see Table
S1 for sequences). Transfection was performed
with TALEN expression plasmids and/or ssODNs
(12 mg), as indicated. ns indicates control ssODN
lacking homology arms. For Smo-FLAG-PS, we
could initially detect products corresponding to
potential FLAG-tag sequence integration in the
absence of nucleases but realized that this was due
to PCR artifacts, and special care was taken to
exclude PCR artifacts, which included using DNA
extracted 3 weeks after transfection and treating
DNA samples with single-strand DNA nucleases
before PCR (Figure S3). See also Figure S2C for
multiplex tag sequence insertion.
(C) Efficient isolation of clones with FLAG- or
3FLAG-tagged SUFU gene from cells treated
with PS-modified ssODNs. Cell clones were
isolated after transfection with SUFU-specific
TALEN expression plasmids and the indicated PS-
ssODNs. Uppercase labels indicate specific clones analyzed at both DNA and protein levels; Ctl lane corresponds to untreated cells. Protein expression was
analyzed by western blot using anti-FLAG antibody. See also Figure S4 for successful ssODN-mediated KI in rat, mouse, and zebrafish.for toxicity. In the rat and mouse, it was previously reported that
non-modified ssODNs with long homology arms can direct effi-
cient sequence insertion during repair of double-strand breaks
induced by TALEN or CRISPR-Cas9 nucleases whereas, in the
zebrafish, only modest levels of precise sequence insertion
could be achieved (Bedell et al., 2012; Gagnon et al., 2014).
For tests in the rat, we targeted the Cftr gene. ssODNs were
designed with 45-nt homology arms flanking a single A nt that
creates a XbaI restriction site for facile genotyping of Cftrmutant
rats and that simultaneously disrupts the open reading frame of
the Cftr gene and target sequence of the guide RNA (to preventCecleavage of the successfully edited genomic sequence; Fig-
ure S4A). The genome editing strategywas first tested in cultured
rat C6 glioblastoma cells. In line with results described above,
successful insertion, although at very low levels, could be de-
tected when guide RNA and Cas9 expression plasmids were
co-transfected with PS-ssODN, but not with PO-ssODN (Fig-
ure S4A). PS- or PO-ssODNs were next co-injected with guide
RNA and Cas9 mRNA into rat fertilized zygotes. Rat pups born
from the injections were genotyped by PCR and XbaI digestion
as well as by DNA sequencing. Embryo viability and newborn
frequencies were in a similar range with PS- and PO-ssODNs,ll Reports 14, 2263–2272, March 8, 2016 ª2016 The Authors 2267
Table 1. Efficient Genome Editing with PS-Modified ssODNs in Model Organisms
Target Locus ssODN Donor Cas9/sg/ssODN (ng/ml) No. of Newborns No. of E15 No. of KI (%) No. of NHEJ (%)
Rat Cftr gene PS 20/10/15 23 – 6 (26.1) 9 (39)
50/10/15 41 – 13a (31.7) 22 (53.6)
PO 20/10/15 49 – 13a (26.5) 31 (63.3)
50/10/15 65 – 15b +1c (24.6) 34 (52.3)
Mouse ROSA 26 PS 20/10/25 – 8 3d +2e (62.5) 4 (50)
PO 20/10/25 – 21 2 (9.5) 15 (71.4)
(Top) Genome editing with PS- and PO-ssODNs in rat. Two series of injections into rat fertilized oocytes were performed, loading injection pipettes with
a solution containingCftr guide RNA, Cas9 mRNA, and Cftr PS- or PO-ssODN as indicated (sequence information is provided in Figure S4A). Tail DNA
was extracted from newborns, and targeted modification of the Cftr gene was examined by PCR and XbaI digestion to quantitate the insertion effi-
ciency (Figure S4A), as well as by PCR and high-resolution DNA capillary electrophoresis to quantitate indel mutations. Quantifications and sequence
modifications were confirmed by DNA sequencing of PCR products. Rats that are heterozygotes with one KI and one NHEJ event are included in both
KI and NHEJ animal counts indicated in the table. See also Figure S4A.
(Bottom) Genome editing with PS- and PO-ssODNs in mouse. Injection was performed in mouse oocytes with a solution containing Rosa guide RNA,
Cas9mRNA, andRosa-PS- or PO-ssODN as indicated (see experimental design in Figure S4B). DNA fromE15 embryoswas extracted, and insertion of
loxP sequence was analyzed by PCR and BglII digestion to evaluate insertion rate (Figure S4B) and confirmed by sequencing of PCR products. Mice
that are heterozygotes with one KI and one NHEJ event are included in both KI and NHEJ animal counts indicated in the table. See also Figure S4B.
aIncluding one homozygous KI animal.
bIncluding four homozygous KI animals.
cAll KI events corresponded to precise sequence insertion, except for one KI obtained with the PO-ssODN, which showed a double copy of ODN
sequence.
dIncluding three homozygous KI mice.
eThe insertion events are precise for all embryos except two: one that had a 137-bp deletion on the 50 side of the insert and the other two point de-
letions, one on each side of the insert.indicating that no specific toxicity was associated with PS-
compared to PO-ssODNs (Figure S4A). Strikingly, a high propor-
tion of embryos carried the wanted sequence insertion when
either type of ssODN was injected: 24.6%–31.7% of newborns
were KI-positive, and in several rats, KI was detected on both al-
leles. All rats with KI events showed precise integration of the
ssODN, irrespective of the type of ssODN, with the exception
of one rat that showed integration of two ssODN sequences in
tandem after injection of PO-ssODN. NHEJ events were frequent
in all experimental groups (39%–63.3% of newborns), attesting
high efficacy of the guide RNA. In addition, we evaluated the
specificity of ssODN integration using the targeted locus ampli-
fication (TLA) method (de Vree et al., 2014), which allows to
define the genomic integration site of a given exogenous
sequence. The integration sites of the ssODN donor were map-
ped by TLA in a rat that had been found to have precise KI at the
Cftr locus. TLA showed integration of the ssODN at the Cftr lo-
cus, as expected, and not at any other genomic site, demon-
strating that only specific ssODN integration had taken place.
In the mouse, the ssODN was designed to insert at the ROSA
locus a 34-bp loxP sequence, a genome edit of high interest to
generate alleles for conditional gene inactivation with the Cre-
loxP system (Branda and Dymecki, 2004), and a BglII site to
facilitate genotyping (Figure S4B). Zygotes injected with PS- or
PO-ssODN donors were genotyped at the blastocyst stage
(Figure S4B) or at E15 (Table 1). In contrast to the results at the
rat Cftr locus, co-injection of PS-ssODN led to a much-higher
efficiency of sequence insertion (62.5% versus 9.5% with PO-
ssODN). Notably, several E15 embryos carried KI at both alleles
when using PS-ssODN whereas none was found with PO-
ssODN. In both groups, the rates of NHEJ-modified mice were2268 Cell Reports 14, 2263–2272, March 8, 2016 ª2016 The Authorscomparable (50%and 71.4%). As observed in rats, survival rates
were equivalent with the PS- and the PO-ssODN donors (Fig-
ure S4B). Because the experimental injection setup and initial
stages of mouse and rat embryo development are highly similar,
it was surprising that the benefit of PS-ssODNs was much more
dramatic in the mouse. One possibility is that PS-ssODNs were
much more efficient because the sequence edit was much
longer in the mouse experiment, a 40-nt insertion compared to
2-nt deletion in the rat, and insertion of long sequences is likely
less efficient, making the PO-ssODNs suboptimal.
Finally, we tested PS-ssODNs targeting a GFP transgene in
zebrafish. After co-injection of PS-ssODN with GFP-specific
TALEN proteins, GFP-negative embryos were analyzed individu-
ally for sequence modification at the target locus by deep
sequencing. As previously reported with PO-ssODNs, only very
low levels of precise donor sequence insertion were obtained
(Figure 3A). In one embryo (E8), however, a high proportion of
precise donor insertion was detected, likely due to insertion at
early cleavage stages. Although PS-ssODN did not allow to
improve the rate of precise sequence insertion in zebrafish em-
bryos, one embryo exhibited sufficient levels of precise KI to
expect germline transmission.
Indels Found in Imprecise KI Are Asymmetrically
Positioned
The detailed analysis of sequences corresponding to imprecise
KI in zebrafish exhibited some specific characteristics. We
observed that in a large majority of cases, the sequence modifi-
cations (relative to the expected, precise KI) were located on the
50 side of the 7-bp insert (Figure 3A). Asymmetry was also noted
in some imprecise KI events resulting from using PO-ssODNs
AB
Figure 3. Nature of Imprecise KI Events
Using Sequence-Specific Nucleases and
ssODNs
(A) Test of genome editing with PS-modified ODNs
in zebrafish. (Upper panel) TALEN target se-
quences (in bold) around the fluorophore-specific
codon of the GFP gene (underlined). A PS-ssODN,
carrying two phosphorothioate linkages at both 50
and 30 ends, was designed to introduce a 7-bp
sequence including a PvuII site (in blue lowercase)
into GFP cDNA, resulting in frame shift and GFP
inactivation. Preliminary transfection experiments
were conducted in cells stably expressing GFP to
demonstrate that efficient GFP inhibition could
be induced by co-transfection of GFP-specific
TALENs together with PS-ODNs and GFP-ss2-PS
(Figure S4C). (Middle panel) The PS-ssODN was
co-injected together with GFP-specific TALEN
proteins into one-cell-stage zebrafish embryos
carrying a ubiquitously expressed GFP transgene,
and GFP-negative transgenic embryos were
identified. Single GFP-negative embryos (E1–E8)
were lysed in PCR buffer and the GFP target
sequence amplified and PvuII-digested to evaluate
the insertion efficiency. (Lower panel) Genotyping
was performed by deep sequencing of PCR
products. The three most-frequent sequences
corresponding to imprecise KI (KI+indels) in E8
embryos are shown with the expected KI
sequence (Precise KI) reported on the top as a
reference (insert in bold blue).
(B) Examples of imprecise KI events obtained in
U2OS cells. The most-frequent imprecise KI products are shown for U2OS cells treated with TALEN targeting the AAVS1 locus in the presence of the ssFRTs-PS
or ssFRTas-PS donors that were designed to introduce a 34-bp-long FRT insert sequence (insert in bold blue).
In (A) and (B), imprecise KI sequences correspond to FRT insertion exhibiting additional indels on the 50 side of the insert sequence, referring to the ssODN
sequence orientation.with TALENs in zebrafish (Bedell et al., 2012). We therefore
examined in more detail the imprecise insertions detected previ-
ously in U2OS cells treated with ssODNs. We analyzed DNA of
cells treated with guide RNA sgT2 and ss3s-PS or ss3as-PS,
or with TALEN and ss2s-PS or ss2as-PS, and we focused on
sequences including indels in addition to the insert sequence
50-cagctg-30. We observed that there is an asymmetry in the
location of indels: they are mainly located on the 50 side of the
edit with ss3s donor as in zebrafish and on the 30 side for the
ss3as donor. In other words, referring to the ssODN sequence,
indels are always present on the 50 side of the insert in the ssODN
sequence (Table 2). In order to further analyze imprecise inser-
tion events, we also sequenced the AAVS1 target locus after
treatment with AAVS1-specific TALEN and an ssODN donor de-
signed to introduce a 34-bp-long FRT sequence. In a majority of
cases, imprecise insertions exhibited either indels at the AAVS1
sequence next to the complete insert sequence or partial FRT
sequence insertions with deletions of the insert and adjacent
AAVS1 sequence. In both cases, indels were asymmetrically
localized, being predominantly on the 50 side (referring to the
ODN sequence; Figure 3B; Table 2). Other types of imprecise
KI (exhibiting indels on the 30 side or more-complex insertion
events) were observed in much-lower proportions. It is inter-
esting to note that, compared to ss2 or ss3 donors, imprecise
KI events were slightly more frequent for the FRT donor, whichCecorresponds to insertion of a longer sequence and could be
more error prone. In rat, all KI events obtained with PS-ssODN
were precise, whereas in mouse, two out of five KI included in-
dels. The results reported are consistent with a model for
ssODN-mediated genome editing dependent on two steps of
single-strand annealing, as proposed in yeast (Storici et al.,
2006), which is shown in Figure S5 and further discussed below.
DISCUSSION
Here, we demonstrated that chemically modified ssODNs pro-
vide several important benefits to the design of ssODN donors
for genome editing. Remarkably, we showed that the use of
PS-ssODN donors can give rise to much-higher levels of KI,
especially for long inserts, both in cells and in rodents. Chemical
modifications, PS or LNA, stabilize ssODNs and probably
contribute by increasing the effective concentration of ssODN
available during DNA repair. Recently, chemically modified guide
RNAs were also demonstrated to improve genome editing
(Hendel et al., 2015), and chemical modification of different types
of linear donors used in genome editing (Sargent et al., 2011)
might also be beneficial, as shown here for short ss and dsODNs.
PS-ssODNs have been documented to be toxic or inhibit cell
proliferation (Rios et al., 2012), but we found here, however,
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Table 2. Asymmetry of Indels Found in Imprecise KI in U2OS Cells
Total Reads % Precise KI
% Imprecise KI
% KI + 50 Indels % KI + Other Indels
sgT2+Cas9+ss3s-PS 169,890 11.2 1.1 –
sgT2+Cas9++ss3as-PS 154,707 8.1 1.2 0.1
TALEN+ss2s-PS 13,748 14.7 1.5 –
TALEN+ss2as-PS 32,186 15 1.8 0.6
TALEN+ssFRTs-PS 106,778 20.8 5 0.1
TALEN+ssFRTas-PS 88,714 18.9 3.1 0.1
The percent of DNA target sequences with precise insertion (precise KI) and imprecise insertion exhibiting indels on the 50 side of the insert, referring to
the ssODN sequence orientation, (KI + 50 indels) or other types of indels (KI + other indels) were evaluated by deep sequencing and are indicated for
different pairs of nucleases and ssODNs, corresponding to either target sequence orientation (s or as). In all cases, the large majority of imprecise KI
sequences exhibit additional indels on the 50 side of the insert sequence, except in the case of TALEN+ss2as-PS. In the latter case, additional indels
were likely induced by a second step of DNA cleavage by TALENs and NHEJ repair after an initial precise KI event. Indeed, the 7-bp insert resulted in a
22-bp-long spacer between the two TALEN-binding sites that still allowed for DNA cleavage by TALENs (as checked in vitro; not shown) and gener-
ation of additional indels after precise KI.targeted sequence insertion is readily achieved. Concerning the
homology length, we showed that as short as 20 nt on each side
of the break is sufficient when using PS-ssODNs. Including
modified nucleotides in the donor therefore allows to decrease
the homology length while maintaining activity and therefore
significantly increases design flexibility. The main advantage is
to be able tomake longer sequence insertions. Here, a sequence
insertion of more than 100 bp could be achieved, allowing the
insertion of multiple tags that are useful for protein functional
analysis. In ssODN design, the distance between the insertion
and cleavage sites is also an important parameter that may
benefit from ODN chemical modification because, in practice,
cleavage sites are limited to sequences adjacent to NGG or
NGA PAM motifs of S pyogenes Cas9 and its VQR variant,
respectively (Kleinstiver et al., 2015; Zetsche et al., 2015). We
found that a distance of 20 bp still allows for very efficient
sequence insertion with PS-ssODN.
Concerning the specificity of integration events, we used the
recently described approach, TLA (de Vree et al., 2014), to un-
cover potential off-target insertion sites. Analyzing one KI rat,
we observed no insertion of the ssODN outside of the targeted
loci, demonstrating specificity. ssODN integration seems to be
a highly specific process because it needs both genomic cleav-
age and homologous regions, allowing stable base pairing near
the break.
In addition to ssODNs, we also evaluated short microhomol-
ogy-containing duplex donors and showed that chemically
modified duplexes also exhibit increased insertion activity. How-
ever, very poor levels of precise KI were obtained. Enhancement
of MMEJ repair pathways or reduction of NHEJ and better
understanding of the mechanisms involved in microhomology-
based duplex insertion might increase the precision of sequence
insertion and reduce NHEJ-dependent sequence modifications.
Using the recently described RNA-guided nuclease Cpf1,
which generates 50mh, instead of Cas9 could also improve the
precision of insertion events by providing more-appropriate
‘‘acceptor’’ ends (Zetsche et al., 2015).
With ssODN donors, the insertion events are mostly precise in
many biological systems, such as human cell lines or rodents, as2270 Cell Reports 14, 2263–2272, March 8, 2016 ª2016 The Authorsreported here. In contrast, in zebrafish, imprecise KI events are
predominant. In the latter case, phenotypic screening was per-
formed here with GFP and made it possible to identify embryos
with thewanted sequence insertion by screening a limited number
of embryos. Phenotypic screening could also be performed at a
control pigmentation locus, easily targeted in parallel to the locus
of interest by co-injection of specific guide RNA, in order to select
for embryoswhere genomemodificationefficiently tookplace and
help limit the number of animals to be raised and screened.
ssODN-mediated genome editing is likely not mediated by the
classical homologous recombination pathway, which involves
double-stranded DNA template during repair (Majumdar et al.,
2008; Storici et al., 2006). Based on our analysis of sequences
from imprecise KI events, we propose that genome editing
with ssODN takes place by two steps of single-strand annealing
as proposed in yeast (Figure S5; Storici et al., 2006), and it will be
interesting to test the direct contribution of components of the
single-strand annealing (SSA) pathway. Better understanding
the factors underlying ssODN-based genome editing and
cross-regulations between DNA repair pathways may help to
stimulate genome editing efficiency in different cellular contexts,
as shown inDrosophila (Beumer et al., 2013a) or more recently in
mouse embryos, where LIG4 inhibition allowed to favor KI events
(Chu et al., 2015). In conclusion, we propose here an optimized
KI approach based on PS-modified ssODN donors and validate
its improved activity in different biological systems, both in
cultured cells and in vivo. Such scalable and robust approach
should be useful for precise sequence manipulation, expanding
the versatility and applicability of genome editing with sequence-
specific nucleases.
EXPERIMENTAL PROCEDURES
Plasmid, oligonucleotide, RNA, and TALEN materials are detailed in Supple-
mental Information.
Cell Transfection
The human cell lines U2OS, RPE1, and rat C6 cells (ATCC) were nucleofected
(53 105106 cells; kit V [Lonza] and Amaxa program X-001) with 2 mg of each
TALEN or 2 mg of each Cas9 and guide RNA plasmids.
Microinjections into Rat, Mouse, and Zebrafish One-Cell-Stage
Embryos
One-cell-stage rat and mouse zygotes were microinjected by standard proce-
dures. For zebrafish injections, ubi:eGFP line from Mosimann lab was used
(ubiquitous eGFP expression driven by the ubiquitin promoter; see details in
Supplemental Information).
T7EI Mutation Detection and Calculation
T7 Endonuclease I (T7EI) assays were performed as previously described (Pi-
ganeau et al., 2013) using primers in Table S4.
Sequence modification frequencies were estimated as commonly done: in-
del rate = 1  (1  Xc)1/2 with Xc, rate of cleaved products and if Xc < 0.15,
indel rate = Xc/2. For this calculation, the hypothesis is that all heterodu-
plexes formed during hybridation are cleaved by T7E1. If there is, in addition
to wild-type (WT), another homogenous population (X1), as in our KI
experiments here, then the previous hypothesis is not appropriate and
X2 = (1  X1)  (1  Xc  [X1 3 X1])1/2 with X2, heterogeneous mutated pop-
ulation and indel rate = X2 + X1. We observed that, when KI rates are higher
than T7E1 cleavage rates obtained in the absence of donor, the T7E1 assay
was likely not able to cleave all heteroduplexes, especially the ones with the
FLAG sequence insertion (that are abundant when KI rates are high), and
even using the corrected formula, we underestimated the mutation rates. It
is the reason why we chose in these cases to report the rate of T7E1 cleav-
age and not estimated indel rates.
Evaluation of KI Rates
Integration rates were evaluated by RFLP or PCR. DNA was extracted from
transfected cells generally at 6 days after nucleofection. When necessary,
nuclease treatment was done before PCR reaction to eliminate residual
ODN (see details in Supplemental Information). PCR of the target sites was
performed with Phusion polymerase (New England Biolabs). RFLP analysis
was performed on 5 ml of the 25 ml PCR reaction and run on 2.5% agarose
gels. For analysis of tag insertion, small PCR products spanning the insertion
site were resolved on 3% agarose gels and %KI quantified by densitometry
measurements of the bands using ImageJ.
TLA
TLA and next-generation sequencing using primers within the ssODNs (see
Table S5 and Figure S4A) were used to determine the transgenic ssODNs inte-
gration sites as previously described (de Vree et al., 2014).
Amplicon Library Preparation, NGS Sequencing, and Sequence
Analysis
DNA was isolated from transfected cells (EZNA tissue kits; Omega Biotek)
or zebrafish embryos, and 100–150 ng was added to a 50-ml Phusion po-
lymerase (NEB) reaction. Each sample was assigned a primer set with a
unique barcode to enable multiplex sequencing (Table S5). PCR products
were purified on a 2% agarose gel, quantified, and pooled into a single
sample for sequencing. The single combined sample was treated by the
MNHN Genomics Center and sequenced on Ion Torrent PGM. A custom
python pipeline was used to count and characterize indels and insert
types.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and six tables and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2016.02.018.
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